Harvey J. Berger
Directeur Général chez Kojin Therapeutics, Inc.
Profil
Harvey J.
Berger is the founder of ARIAD Pharmaceuticals, Inc., which was founded in 1991.
He held the title of Chairman, President & Chief Executive Officer from 2004 to 2015.
Dr. Berger is currently the Chairman, President & Chief Executive Officer of Kojin Therapeutics, Inc. since 2024.
He is also a Director at the Cameron Boyce Foundation.
In addition, Dr. Berger is a Trustee at Dana-Farber Cancer Institute, Inc. since 2018 and a Member-Deans Council at Yale University and Yale School of Medicine.
Previously, he served as the Executive Chairman-USA Region at Medinol Ltd.
and as EVP, President-Research & Development Division at Centocor, Inc. from 1986 to 1991.
Dr. Berger received his undergraduate degree from Colgate University and his doctorate from Yale School of Medicine.
Postes actifs de Harvey J. Berger
| Sociétés | Poste | Début |
|---|---|---|
| Yale University | Corporate Officer/Principal | - |
| Yale School of Medicine | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 21/02/2018 |
Cameron Boyce Foundation
 Cameron Boyce Foundation Investment Trusts/Mutual FundsMiscellaneous The Cameron Boyce Foundation was founded in 2019 by Cameron Boyce's family to honor his legacy. The non-profit company is based in Sherman Oaks, CA. The foundation aims to cure epilepsy by funding research, education, and awareness campaigns while also supporting causes that were important to Cameron. The foundation is multi-faceted and strives to use the best resources possible to help others and make the world a better place. | Directeur/Membre du Conseil | - |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Directeur Général | 03/01/2024 |
Anciens postes connus de Harvey J. Berger
| Sociétés | Poste | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Directeur Général | 31/12/2015 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Directeur Technique/Scientifique/R&D | 01/01/1991 |
Medinol Ltd.
 Medinol Ltd. Medical SpecialtiesHealth Technology Medinol Ltd. engages in the science of cardiovascular intervention. It researches, develops and manufactures stenting systems. The company was founded by Judith Richter and Jacob Richter in 1992 and is headquartered in Tel Aviv, Israel. | Corporate Officer/Principal | - |
Formation de Harvey J. Berger
| Colgate University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Medinol Ltd.
Medinol Ltd. Medical SpecialtiesHealth Technology Medinol Ltd. engages in the science of cardiovascular intervention. It researches, develops and manufactures stenting systems. The company was founded by Judith Richter and Jacob Richter in 1992 and is headquartered in Tel Aviv, Israel. | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
Cameron Boyce Foundation
Cameron Boyce Foundation Investment Trusts/Mutual FundsMiscellaneous The Cameron Boyce Foundation was founded in 2019 by Cameron Boyce's family to honor his legacy. The non-profit company is based in Sherman Oaks, CA. The foundation aims to cure epilepsy by funding research, education, and awareness campaigns while also supporting causes that were important to Cameron. The foundation is multi-faceted and strives to use the best resources possible to help others and make the world a better place. | Miscellaneous |
